hydrogen sulfide has been researched along with Diabetic Glomerulosclerosis in 25 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Accumulating evidence has demonstrated that hydrogen sulfide (H2S) plays critical roles in the pathogenesis of chronic kidney diseases." | 3.80 | Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model. ( Chen, J; Feng, Y; Zhan, Z; Zhou, X, 2014) |
| "NO generation in Type 2 diabetes with nephropathy is inversely associated with the dimethyl-arginine concentrations, which are therefore important modulators of NO synthesis independently from the classic stimulatory pathways (such as the insulin effect)." | 2.52 | Nitric oxide in the normal kidney and in patients with diabetic nephropathy. ( Tessari, P, 2015) |
| "In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO)." | 1.42 | Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes. ( Choudhury, GG; Feliers, D; Gorin, Y; Kasinath, BS; Lee, HJ; Mariappan, MM; Sataranatarajan, K, 2015) |
| "Hydrogen sulfide (H(2)S) has recently been found to play beneficial roles in ameliorating several diseases, including hypertension, atherosclerosis and cardiac/renal ischemia-reperfusion injuries." | 1.39 | Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy. ( Imai, E; Kimura, T; Kojima, H; Kosugi, T; Maruyama, S; Matsuo, S; Niki, I; Sato, W; Taniguchi, S; Yamamoto, J; Yamamoto, T; Yuzawa, Y, 2013) |
| "Hydrogen sulfide is a newly identified modulator of protein synthesis in the kidney, and reduction in its generation may contribute to kidney injury in diabetes." | 1.38 | Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. ( Abboud, HE; Cavaglieri, RC; Choudhury, GG; Feliers, D; Kasinath, BS; Lee, HJ; Mariappan, MM; Sataranatarajan, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 7 (28.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, KF | 1 |
| Pfeilschifter, J | 1 |
| Dugbartey, GJ | 2 |
| Bushell, CJ | 1 |
| Forgan, LG | 1 |
| Aston-Mourney, K | 1 |
| Connor, T | 1 |
| McGee, SL | 1 |
| McNeill, BA | 1 |
| Sun, HJ | 1 |
| Wu, ZY | 1 |
| Cao, L | 1 |
| Zhu, MY | 1 |
| Liu, TT | 1 |
| Guo, L | 1 |
| Lin, Y | 1 |
| Nie, XW | 1 |
| Bian, JS | 1 |
| Elbassuoni, EA | 1 |
| Аziz, NM | 1 |
| Habeeb, WN | 1 |
| Uyy, E | 1 |
| Suica, VI | 1 |
| Boteanu, RM | 1 |
| Safciuc, F | 1 |
| Cerveanu-Hogas, A | 1 |
| Ivan, L | 1 |
| Stavaru, C | 1 |
| Simionescu, M | 1 |
| Antohe, F | 1 |
| Hussain Lodhi, A | 1 |
| Ahmad, FU | 2 |
| Furwa, K | 1 |
| Madni, A | 1 |
| Yu, Y | 1 |
| Xiao, L | 1 |
| Ren, Z | 1 |
| Zhu, G | 1 |
| Wang, W | 1 |
| Jia, Y | 1 |
| Peng, A | 1 |
| Wang, X | 1 |
| John, AMSP | 1 |
| Kundu, S | 3 |
| Pushpakumar, S | 3 |
| Fordham, M | 1 |
| Weber, G | 1 |
| Mukhopadhyay, M | 1 |
| Sen, U | 4 |
| Yu, YT | 1 |
| Yang, JW | 1 |
| Pushpakumar, SB | 1 |
| Tyagi, A | 1 |
| Coley, D | 1 |
| Zhou, X | 1 |
| Feng, Y | 1 |
| Zhan, Z | 1 |
| Chen, J | 1 |
| Tessari, P | 1 |
| Li, H | 1 |
| Feng, SJ | 1 |
| Zhang, GZ | 1 |
| Wang, SX | 1 |
| Safar, MM | 1 |
| Abdelsalam, RM | 1 |
| Lee, HJ | 3 |
| Feliers, D | 3 |
| Mariappan, MM | 3 |
| Sataranatarajan, K | 2 |
| Choudhury, GG | 2 |
| Gorin, Y | 2 |
| Kasinath, BS | 3 |
| Qian, X | 1 |
| Li, X | 1 |
| Ma, F | 1 |
| Luo, S | 1 |
| Ge, R | 1 |
| Zhu, Y | 1 |
| Lee, DY | 1 |
| Ghosh-Choudhury, G | 1 |
| Abboud, HE | 2 |
| Cavaglieri, RC | 1 |
| Sattar, MA | 1 |
| Rathore, HA | 1 |
| Abdullah, MH | 1 |
| Tan, S | 1 |
| Abdullah, NA | 1 |
| Johns, EJ | 1 |
| Yuzawa, Y | 2 |
| Yamamoto, J | 1 |
| Sato, W | 1 |
| Kosugi, T | 1 |
| Yamamoto, T | 1 |
| Kimura, T | 1 |
| Taniguchi, S | 1 |
| Kojima, H | 1 |
| Maruyama, S | 1 |
| Imai, E | 1 |
| Matsuo, S | 1 |
| Niki, I | 1 |
8 reviews available for hydrogen sulfide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The Pathophysiology of H
Topics: Animals; Carbon Monoxide; Diabetic Nephropathies; Endothelial Cells; Gasotransmitters; Hydrogen Sulf | 2022 |
Physiological role of hydrogen sulfide in the kidney and its therapeutic implications for kidney diseases.
Topics: Diabetic Nephropathies; Humans; Hydrogen Sulfide; Hypertension, Renal; Kidney; Nephritis | 2023 |
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.
Topics: Animals; Diabetic Nephropathies; Drug Evaluation, Preclinical; Fibrosis; Humans; Hydrogen Sulfide; K | 2019 |
[Protective Effect of Hydrogen Sulfide in the Secondary Renal Disease and Renal Transplantation].
Topics: Animals; Antioxidants; Apoptosis; Diabetic Nephropathies; Humans; Hydrogen Sulfide; Inflammation; Ki | 2016 |
Nitric oxide in the normal kidney and in patients with diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Type 2; Diabetic | 2015 |
Mini-review: diabetic renal complications, a potential stinky remedy.
Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Humans; Hydrogen Sulfide | 2016 |
Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
Topics: Animals; Diabetic Nephropathies; Humans; Hydrogen Sulfide; Kidney; Oxidative Stress; Renin-Angiotens | 2017 |
[Role of hydrogen sulfide in chronic kidney disease and diabetic nephropathy].
Topics: Animals; Chronic Disease; Diabetic Nephropathies; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Hy | 2012 |
17 other studies available for hydrogen sulfide and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Characterisation of the hydrogen sulfide system in early diabetic kidney disease.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Endothelial Cells; Glucose; Hydrogen Sulfide; Ki | 2023 |
The role of activation of K
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Diabetes Mellitus, Experimental; Diabetic | 2020 |
Diabetic nephropathy associates with deregulation of enzymes involved in kidney sulphur metabolism.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Gene Expression | 2020 |
Role of Oxidative Stress and Reduced Endogenous Hydrogen Sulfide in Diabetic Nephropathy.
Topics: Animals; Antioxidants; Diabetic Nephropathies; Dose-Response Relationship, Drug; Hydrogen Sulfide; M | 2021 |
Glucose-induced decrease of cystathionine β-synthase mediates renal injuries.
Topics: Animals; Cystathionine beta-Synthase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gluco | 2021 |
GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney.
Topics: Animals; Collagen; Diabetic Nephropathies; Disease Models, Animal; Endothelial Cells; Hydrogen Sulfi | 2017 |
Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.
Topics: Animals; Cells, Cultured; Diabetic Nephropathies; Dizocilpine Maleate; Endothelial Cells; Excitatory | 2013 |
Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model.
Topics: Animals; Basement Membrane; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Nephropath | 2014 |
Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.
Topics: Adult; Aged; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Diabet | 2014 |
H2S donors attenuate diabetic nephropathy in rats: Modulation of oxidant status and polyol pathway.
Topics: Aldehyde Reductase; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; | 2015 |
MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.
Topics: Animals; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetic Nephropathies; Extracellul | 2015 |
Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes.
Topics: AMP-Activated Protein Kinases; Animals; Calcium; Carbolines; Diabetic Nephropathies; Extracellular M | 2015 |
Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy.
Topics: Animals; Cell Proliferation; Cell Size; Cells, Cultured; Cysteine; Diabetes Mellitus, Experimental; | 2016 |
Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells.
Topics: Amidines; AMP-Activated Protein Kinases; Animals; Benzylamines; Diabetic Nephropathies; Epithelial C | 2017 |
Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
Topics: Adaptor Proteins, Signal Transducing; Air Pollutants; AMP-Activated Protein Kinase Kinases; AMP-Acti | 2012 |
Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Diabetic Nephropathies; Disease Progression; Hydrogen Sulfide; Hypertension | 2012 |
Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy.
Topics: Animals; Calmodulin; Capillaries; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes M | 2013 |